Imaging of prostate cancer.

[1]  R B Jeffrey,et al.  Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. , 1987, Radiology.

[2]  J. Platt,et al.  The accuracy of CT in the staging of carcinoma of the prostate. , 1987, AJR. American journal of roentgenology.

[3]  Herbert Y. Kressel,et al.  Prostatic carcinoma: staging with MR imaging at 1.5 T. , 1988 .

[4]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[5]  M. Soloway,et al.  Transrectal ultrasound for staging prior to radical prostatectomy. , 1989, Urology.

[6]  P. Scardino,et al.  Pathologic basis of the sonographic appearance of the normal and malignant prostate. , 1989, The Urologic clinics of North America.

[7]  P. Scardino,et al.  The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. , 1989, The Journal of urology.

[8]  H. Schmidt,et al.  [The clinical value of preoperative staging of bladder and prostatic cancers with nuclear magnetic resonance and computerized tomography]. , 1989, Der Urologe. Ausg. A.

[9]  G. Chodak,et al.  Assessment of value of routine bone scans in patients with newly diagnosed prostate cancer. , 1991, Urology.

[10]  C. Gatsonis,et al.  Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. , 1990, The New England journal of medicine.

[11]  S. Torp-Pedersen,et al.  Local staging of prostate cancer with transrectal ultrasound: A literature review , 1992, The Prostate. Supplement.

[12]  J. Oesterling,et al.  Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications. , 1993, The Urologic clinics of North America.

[13]  R. Troiano,et al.  Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma. , 1993, AJR. American journal of roentgenology.

[14]  W. Catalona,et al.  Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.

[15]  J. Oesterling,et al.  The clinical usefulness of prostate specific antigen: update 1994. , 1994, The Journal of urology.

[16]  V. Nicolas,et al.  MR-Tomographie des Prostatakarzinoms - Vergleich konventionelle und endorektale MRT , 1994 .

[17]  U. Norming,et al.  Cost‐effectiveness analysis in early detection of prostate cancer: An evaluation of six screening strategies in a randomly selected population of 2,400 men , 1995, The Prostate.

[18]  P. Carroll,et al.  Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. , 1996, Urology.

[19]  J. Witjes,et al.  Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. , 1996, AJR. American journal of roentgenology.

[20]  P. Carroll,et al.  Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. , 1996, AJR. American journal of roentgenology.

[21]  H. Thaler,et al.  Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? , 1996, The Journal of urology.

[22]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[23]  A. Aschoff,et al.  Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy. , 1997, The British journal of radiology.

[24]  J. Silverman,et al.  MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. , 1997, AJR. American journal of roentgenology.

[25]  R Alagappan,et al.  Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. , 1997, Radiology.

[26]  J A Smith,et al.  Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. , 1997, The Journal of urology.

[27]  G. Murphy,et al.  ProstaScint® scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: Analysis of 136 scans of 100 patients , 1998 .

[28]  M. Banerjee,et al.  Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. , 1998, The Journal of urology.

[29]  A. Martinez,et al.  The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology. , 1998, International journal of radiation oncology, biology, physics.

[30]  K. Taari,et al.  Magnetic resonance imaging of clinically localized prostatic cancer. , 1998, The Journal of urology.

[31]  F. Obuz,et al.  Is Magnetic Resonance Imaging Necessary in the Staging of Prostate Cancer? , 1999, Urologia Internationalis.

[32]  H. Hricak,et al.  Imaging prostate cancer. , 1999, The Journal of urology.

[33]  J Kurhanewicz,et al.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.

[34]  A. Partin,et al.  Comparison of clinical staging algorithms and 111Indium‐capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients , 1999, Cancer.

[35]  O. Halvorsen,et al.  MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy , 1999, European Radiology.

[36]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[37]  J. Hanley,et al.  The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. , 2000, The Journal of urology.

[38]  H. Hricak,et al.  Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging , 2000, Magnetic resonance in medicine.

[39]  O. Hélénon,et al.  Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. , 2000, AJR. American journal of roentgenology.

[40]  M. Carducci,et al.  Management of patients with rising prostate-specific antigen after radical prostatectomy. , 2000, Urology.

[41]  E. Halpern,et al.  Prostate cancer: contrast-enhanced us for detection. , 2001, Radiology.

[42]  C C Schulman,et al.  Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.

[43]  N. Avril,et al.  Diagnosis and Monitoring of Urological Tumors Using Positron Emission Tomography , 2001, European Urology.

[44]  T Okada,et al.  Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. , 2001, Urology.

[45]  P. Lange,et al.  PROSTASCINT scan for staging prostate cancer. , 2001, Urology.

[46]  M. Terris,et al.  Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. , 2001, Urology.

[47]  P. Dettmar,et al.  Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer , 2001, BJU international.

[48]  S. Shariat,et al.  Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. , 2001, Radiology.

[49]  D. Piers,et al.  Routine bone scans in patients with prostate cancer related to serum prostate‐specific antigen and alkaline phosphatase , 2001, BJU international.

[50]  K. Taari,et al.  Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences , 2001, European Radiology.

[51]  William J Catalona,et al.  Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.

[52]  D. Mathews,et al.  Positron emission tomography in prostate and renal cell carcinoma , 2002, Current opinion in urology.

[53]  M. Terris.  Prostate biopsy strategies: past, present, and future. , 2002, The Urologic clinics of North America.

[54]  S. Kosuda,et al.  Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? , 2002, Cancer.

[55]  O. Hélénon,et al.  Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. , 2002, Radiology.

[56]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[57]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[58]  M. Cooperberg,et al.  Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor. , 2002, The Journal of urology.

[59]  J. J. de la Rosette,et al.  Value of contrast ultrasonography in the detection of significant prostate cancer: Correlation with radical prostatectomy specimens , 2002, The Prostate.

[60]  N. Sadato,et al.  11C-acetate PET imaging of prostate cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[61]  Bernd Hamm,et al.  Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.